Which epigenetic and inflammation related biomarkers can identify clinically aggressive prostate cancer
ABSTRACT: Prostate cancer is a highly prevalent malignancy and a major cause of cancer-related morbidity and mortality. Radical prostatectomy technique remains the major treatment opbon for men with potenbal cure and life expectancy exceeding 10 years. In the very recent 2018 published follow-up of...
| Autor principal: | |
|---|---|
| Formato: | doctoralThesis |
| Idioma: | eng |
| Publicado em: |
2020
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10362/105510 |
| País: | Portugal |
| Oai: | oai:run.unl.pt:10362/105510 |